4.2 Review

HIV and comorbidities - the importance of gut inflammation and the kynurenine pathway

Journal

CURRENT OPINION IN HIV AND AIDS
Volume 18, Issue 2, Pages 102-110

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/COH.0000000000000782

Keywords

dysbiosis; geroscience; HIV; kynurenine; microbiome; microbiota; senotherapeutics

Ask authors/readers for more resources

The article reviews alterations in microbiota composition, diversity, and functional features in relation to chronic inflammation and comorbidities associated with HIV infection. The gut microbiome plays a crucial role in host immunity, and disruption of gut homeostasis can lead to systemic inflammation and immune activation. Ageing and HIV share similar features of intestinal damage and changes in bacterial composition, contributing to a proinflammatory state and age-related comorbidities. The nicotinamide adenine dinucleotide (NAD+)-producing kynurenine pathway (KP) is explored as a potential inflammatory pathway involved in metabolic changes and age-related diseases in PWH.
Purpose of reviewThe purpose of this article is to review alterations in microbiota composition, diversity, and functional features in the context of chronic inflammation and comorbidities associated with HIV infection.Recent findingsThe gut microbiome is an important mediator of host immunity, and disruption of gut homeostasis can contribute to both systemic inflammation and immune activation. Ageing and HIV share features of intestinal damage, microbial translocation and alterations in bacterial composition that contribute to a proinflammatory state and development of age-related comorbidities. One such inflammatory pathway reviewed is the nicotinamide adenine dinucleotide (NAD+) producing kynurenine pathway (KP). Kynurenine metabolites regulate many biological processes including host-microbiome communication, immunity and oxidative stress and the KP in turn is influenced by the microbiome environment. Age-associated decline in NAD+ is implicated as a driving factor in many age-associated diseases, including those seen in people with HIV (PWH). Recent studies have shown that KP can influence metabolic changes in PWH, including increased abdominal adiposity and cardiovascular disease. Furthermore, KP activity increases with age in the general population, but it is elevated in PWH at all ages compared to age-matched controls. Host or microbiome-mediated targeting of this pathway has merits to increase healthy longevity and has potential therapeutic applications in PWH.As a growing proportion of PWH age, many face increased risks of developing age-related comorbidities. Chronic inflammation, a pillar of geroscience, the science of ageing and of age-related disease, is influenced by the gut microbiome and its metabolites. Combined, these contribute to a systemic inflammatory signature. Advances in geroscience-based approaches and therapeutics offer a novel paradigm for addressing age-related diseases and chronic inflammation in HIV infection. Whether targeted inhibition of KP activity alleviates pathological conditions or promotes successful ageing in PWH remains to be determined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available